Alvotech faces challenges with potential tariffs and profitability, despite strong revenue growth and a robust pipeline. See ...

A hit shows that there is “at least in principle, a molecule out there in the universe that does what I want it to,” he says. “At least it de-risks the concept.” In addition to considering ...

Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Aapistie 5 A, 90220 Oulu, Finland Biocenter Oulu, University of Oulu, Aapistie 5 A, 90220 Oulu, Finland ...

J&J’s fading immunology star Stelara, meanwhile, suffered a setback in the quarter as biosimilars crept into the market. Another headwind was changes to the Medicare’s Part D policies. The drug pulled ...

No significant differences in the risk of myocardial infarction, ischemic stroke, or cardiovascular-related death were observed in patients with psoriasis or psoriatic arthritis initiating treatment ...

The concerns around the Stelara exclusivity appear overblown. China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley. Get the ...

Researchers at the University of Gothenburg have identified a molecule that helps more mitochondria function properly. Mitochondrial diseases caused by POLG mutations vary in severity. In young ...

Get Instant Summarized Text (Gist) A new AI method integrates large language models (LLMs) with graph-based models to enhance molecule creation, improving efficiency and explainability. This ...

This positive outlook comes despite anticipated challenges, including the introduction of a Stelara biosimilar, significant foreign exchange headwinds impacting EPS by up to $0.25, and changes to ...

Biosimilars are not exact copies like generics for traditional small molecule drugs ... in 2023 and Janssen’s immunology medication Stelara this year, which cost about $7,000 and $10,000 ...